Compare The Cooper Cos., Inc. with Similar Stocks
Dashboard
1
Poor long term growth as Operating profit has grown by an annual rate 13.84% of over the last 5 years
2
Negative results in Oct 25
3
With ROCE of 6.40%, it has a very expensive valuation with a 1.56 Enterprise value to Capital Employed
4
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
USD 14,174 Million (Mid Cap)
38.00
NA
0.00%
0.30
4.55%
1.72
Revenue and Profits:
Net Sales:
1,024 Million
(Quarterly Results - Jan 2026)
Net Profit:
131 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.65%
0%
-12.65%
6 Months
12.02%
0%
12.02%
1 Year
-9.84%
0%
-9.84%
2 Years
-28.46%
0%
-28.46%
3 Years
-78.9%
0%
-78.9%
4 Years
-82.76%
0%
-82.76%
5 Years
-80.82%
0%
-80.82%
The Cooper Cos., Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.98%
EBIT Growth (5y)
13.84%
EBIT to Interest (avg)
9.81
Debt to EBITDA (avg)
2.54
Net Debt to Equity (avg)
0.30
Sales to Capital Employed (avg)
0.36
Tax Ratio
34.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
5.85%
ROE (avg)
13.03%
Valuation key factors
Factor
Value
P/E Ratio
38
Industry P/E
Price to Book Value
1.72
EV to EBIT
24.31
EV to EBITDA
15.66
EV to Capital Employed
1.56
EV to Sales
4.06
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.40%
ROE (Latest)
4.55%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot : Jan 2026
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 134 Schemes (53.21%)
Foreign Institutions
Held by 375 Foreign Institutions (26.68%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jan'26 - QoQ
Jan'26
Oct'25
Change(%)
Net Sales
1,024.10
1,065.20
-3.86%
Operating Profit (PBDIT) excl Other Income
212.80
238.80
-10.89%
Interest
28.60
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
130.80
84.60
54.61%
Operating Profit Margin (Excl OI)
207.80%
131.80%
7.60%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jan 2026 is -3.86% vs 0.46% in Oct 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jan 2026 is 54.61% vs -13.94% in Oct 2025
Annual Results Snapshot (Consolidated) - Oct'25
Oct'25
Oct'24
Change(%)
Net Sales
4,092.40
3,895.40
5.06%
Operating Profit (PBDIT) excl Other Income
1,105.90
1,119.50
-1.21%
Interest
63.90
59.30
7.76%
Exceptional Items
0.00
0.00
Consolidate Net Profit
374.90
392.30
-4.44%
Operating Profit Margin (Excl OI)
166.90%
181.20%
-1.43%
USD in Million.
Net Sales
YoY Growth in year ended Oct 2025 is 5.06% vs 8.41% in Oct 2024
Consolidated Net Profit
YoY Growth in year ended Oct 2025 is -4.44% vs 33.34% in Oct 2024
About The Cooper Cos., Inc. 
The Cooper Cos., Inc.
Pharmaceuticals & Biotechnology
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision, Inc. and CooperSurgical, Inc. CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses. CooperVision services three primary regions: the Americas; Europe, the Middle East and Africa (EMEA), and Asia Pacific. CooperVision offers spherical, aspherical, toric, multifocal and toric multifocal lens products in various modalities. CooperVision's products are primarily manufactured at its facilities located in the United Kingdom, Puerto Rico, Hungary, Costa Rica and New York. CooperSurgical offers an array of products and services focused on advancing the health of families through a portfolio of products and services focusing on women's health, fertility and diagnostics.
Company Coordinates 
Company Details
6101 Bollinger Canyon Rd Ste 500 , SAN RAMON CA : 94583-5177
Registrar Details






